Ignite Creation Date:
2025-12-24 @ 11:11 PM
Ignite Modification Date:
2026-03-05 @ 4:27 PM
Study NCT ID:
NCT04819269
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2021-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Sponsor:
Sylentis, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SYL1001_V
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None